Results 1 to 6 of 6
Page 1 of 1
TypeTitleAuthor(s)YearViews
A multicenter phase II study of sorafenib, capecitabine, and oxaliplatin (SECOX) in patients with advanced hepatocellular carcinoma: final results of Hong Kong-Singapore Hepatocellular Carcinoma Research Collaborative Group studyYau, TCC; Cheung, FY; Lee, F; Choo, SP; Wong, HYH; Toh, HC; Leung, AK; Chan, P; Yau, TK; Wong, J; Tang, YF; Lau, JSM; Cheung, TT; Fan, ST; Poon, RTP201359
 
Toll-like receptor 3 expressing tumor parenchyma and infiltrating natural killer cells in hepatocellular carcinoma patientsChew, V; Tow, C; Huang, C; Bard-Chapeau, E; Copeland, NG; Jenkins, NA; Weber, A; Lim, KH; Toh, HC; Heikenwalder, M; Ng, IOL; Nardin, A; Abastado, JP201222
 
Chemokine-driven lymphocyte infiltration: An early intratumoural event determining long-term survival in resectable hepatocellular carcinomaChew, V; Chen, J; Lee, D; Loh, E; Lee, J; Lim, KH; Weber, A; Slankamenac, K; Poon, RTP; Yang, H; Ooi, LLPJ; Toh, HC; Heikenwalder, M; Ng, IOL; Nardin, A; Abastado, JP2012179
 
Efficacy and tolerability of Sorafenib, Capecitabine and Oxaliplatin (Secox) in patients with advanced hepatocellular carcinoma: a multi-centre phase II study (Abstract)Yau, TCC; Chan, P; Cheung, FY; Lee, AS; Yau, TK; Choo, SP; Toh, HC; Leung, AK; Wong, JS; Wong, S; Lau, J; Pang, RWC; Fan, ST; Poon, RTP2011278
 
The utility of Aspirin in Dukes C and High Risk Dukes B Colorectal cancer--the ASCOLT study: study protocol for a randomized controlled trialAli, R; Toh, HC; Chia, WK; Yau, TCC201165
 
Quick-FLIC: A short questionnaire for assessing quality of life of cancer patientsCheung, YB; Khoo, KS; Wong, ZW; See, HT; Toh, HC; Epstein, RJ; Ng, GY; Tan, SB2003168
 
Page 1 of 1
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download